A diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) was found to benefit patients with irritable bowel disease.

TOP INSIGHT
Low FODMAP diet reduces certain gut bacteria, such as Bifidobacteria, that may be beneficial to health and may reduce inflammation.
Lead researcher Dr Selina Cox from King's College London, said: "While we know that the low FODMAP diet is effective in patients with irritable bowel syndrome (IBS), this is the first randomised, trial showing that it's effective in reducing common gut symptoms. This improves health-related quality of life in patients with IBD when they are in remission".
Inflammatory bowel diseases include Crohn's disease and ulcerative colitis, both of which involve chronic inflammation of the digestive tract. At present, there is no cure for IBD, but symptoms are managed with a combination of anti-inflammatory and immune-modulating medication, and surgery. However, symptoms can persist during periods of disease remission even when they are receiving medication to control gut inflammation, and patients report these symptoms to have a large impact on their life.
Despite the changes in beneficial bacteria, gut inflammation did not appear to increase after the low FODMAP diet in patients with IBD.
"We carried out this randomised controlled trial to establish whether these common gut symptoms in patients with IBD in remission could be managed by the low FODMAP diet. Indeed, this could represent a safe and cost-effective management option." said Professor Kevin Whelan from King's College London.
"In clinical practice, the low FODMAP diet is followed by a phase of gradual FODMAP reintroduction - it is important to establish what the effects of FODMAP reintroduction are on the gut and whether reintroduction reverses the bacterial changes that were observed during the low FODMAP diet," added Dr Selina Cox.
MEDINDIA



Email










